Ultime notizie per TELUS Intl (NYSE:TIXT) Azioni

TELUS Intl

TELUS International (Cda) Inc is a digital customer experience innovator that designs, builds, and delivers next-generation solutions. Its clients include companies across several verticals, including Tech and Games, eCommerce and FinTech, Banking, Financial Services and Insurance, Communications and Media, and Healthcare. The solutions offered by the company include Digital Experience, Customer Experience, Advisory Services, and Back Office and Automation among other services. Geographically, it derives a majority of its revenue from the European region.

TELUS International

TELUS International (Cda) Inc. Subordinate Voting Shares

TELUS International (Cda) Inc

CryoPort (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CYRX#NASDAQ">CYRX</a>) reported quarterly losses of $(0.02) per share which beat the analyst consensus estimate of $(0.31) by 93.55 percent. The company reported quarterly sales of $56.664 million which missed the analyst consensus estimate of $58.042 million by 2.37 percent. This is a 0.90 percent increase over sales of $56.157 million the same period last year.

Earnings

Earnings Beats

Earnings Misses

News

CYRX

CryoPort Q3 2024 GAAP EPS $(0.02) Beats $(0.31) Estimate, Sales $56.664M Miss $58.042M Estimate

Microvision (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MVIS#NASDAQ">MVIS</a>) reported quarterly losses of $(0.07) per share which beat the analyst consensus estimate of $(0.10) by 30 percent. This is a 41.67 percent increase over losses of $(0.12) per share from the same period last year. The company reported quarterly sales of $190.00 thousand which missed the analyst consensus estimate of $2.25 million by 91.56 percent. This is a 81.85 percent decrease over sales of $1.05 million the same period last year.

MVIS

Microvision Q3 EPS $(0.07) Beats $(0.10) Estimate, Sales $190.00K Miss $2.25M Estimate

At current rates, the Company expects negligible year-over-year currency impact on the full year 2024 revenues.
Additionally, Artivion continues to expect adjusted EBITDA growth of between 28% and 34% for the full year 2024 compared to 2023 resulting in an expected range of $69 to $72 million for 2024.

Guidance

AORT

Artivion Narrows FY24 Revenue Outlook From $388M -$396M To $389M - $396M, Est $391.955M

Sprout Social (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SPT#NASDAQ">SPT</a>) reported quarterly earnings of $0.13 per share which beat the analyst consensus estimate of $0.12 by 8.33 percent. The company reported quarterly sales of $102.638 million which beat the analyst consensus estimate of $102.001 million by 0.62 percent. This is a 20.00 percent increase over sales of $85.532 million the same period last year.

Sprout Social Q3 2024 Adj. EPS $0.13 Beats $0.12 Estimate, Sales $102.638M Beat $102.001M Estimate

W&amp;T Offshore (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WTI#NYSE">WTI</a>) reported quarterly losses of $(0.17) per share which beat the analyst consensus estimate of $(0.19) by 10.53 percent. The company reported quarterly sales of $121.372 million which missed the analyst consensus estimate of $122.406 million by 0.84 percent. This is a 14.77 percent decrease over sales of $142.411 million the same period last year.

W&T Offshore Q3 2024 Adj. EPS $(0.17) Beats $(0.19) Estimate, Sales $121.372M Miss $122.406M Estimate

Arcellx (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ACLX#NASDAQ">ACLX</a>) reported quarterly losses of $(0.48) per share which missed the analyst consensus estimate of $(0.37) by 29.73 percent. The company reported quarterly sales of $26.03 million which missed the analyst consensus estimate of $34.37 million by 24.26 percent. This is a 74.03 percent increase over sales of $14.96 million the same period last year.

ACLX

Arcellx Q3 2024 GAAP EPS $(0.48) Misses $(0.37) Estimate, Sales $26.03M Miss $34.37M Estimate

Management

Natural Gas Services Group Announced The Appointment Of Ian Eckert As CFO Effective No Later Than January 5th, 2026. NGS's Current Interim CFO John Bittner Will Continue In that Role Until Mr. Eckert's Start Date

Con Edison CFO Kirk Andrews Says We Are Narrowing And Revising Our 2024 Adjusted EPS Guidance To The Upper Half Of Our Original Range

Cambium Networks (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CMBM#NASDAQ">CMBM</a>) sees Q4 sales of $40.000 million-45.000 million vs $50.03 million estimate.

CMBM

Cambium Networks Sees Q4 Sales $40.000M-45.000M vs $50.03M Est

SEMrush Hldgs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SEMR#NYSE">SEMR</a>) reported quarterly earnings of $0.01 per share which missed the analyst consensus estimate of $0.03 by 66.67 percent. The company reported quarterly sales of $97.400 million which beat the analyst consensus estimate of $96.647 million by 0.78 percent. This is a 23.73 percent increase over sales of $78.718 million the same period last year.

SEMR

SEMrush Hldgs Q3 2024 GAAP EPS $0.01 Misses $0.03 Estimate, Sales $97.400M Beat $96.647M Estimate

Sandstorm Gold (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SAND#NYSE">SAND</a>) reported quarterly sales of $44.700 which missed the analyst consensus estimate of $44.900 million by 100.00 percent. This is a 100.00 percent decrease over sales of $41.324 million the same period last year.

SAND

Sandstorm Gold Q3 Sales $44.700 Miss $44.900M Estimate

nLight (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LASR#NASDAQ">LASR</a>) reported quarterly losses of $(0.08) per share which met the analyst consensus estimate. This is a 20 percent increase over losses of $(0.10) per share from the same period last year. The company reported quarterly sales of $56.13 million which beat the analyst consensus estimate of $55.27 million by 1.55 percent. This is a 10.85 percent increase over sales of $50.63 million the same period last year.

LASR

nLight Q3 Adj $(0.08), Inline, Sales $56.13M Beat $55.27M Estimate

Lumentum Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LITE#NASDAQ">LITE</a>) is looking for Q2 Adj EPS of $0.30-0.40 vs $0.27 analyst estimate. sees sales of $380.000 million-400.000 million vs $354.32 million estimate.

LITE

Lumentum Holdings Sees Q2 Adj EPS $0.30-0.40 vs $0.27 Est; Sees Sales $380.000M-400.000M vs $354.32M Est

Consolidated Edison (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ED#NYSE">ED</a>) reported quarterly earnings of $1.68 per share which beat the analyst consensus estimate of $1.62 by 3.7 percent.

Consolidated Edison Q3 2024 Adj. EPS $1.68 Beats $1.62 Estimate

PDF Solutions (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PDFS#NASDAQ">PDFS</a>) reported quarterly earnings of $0.25 per share which beat the analyst consensus estimate of $0.20 by 25 percent. The company reported quarterly sales of $46.409 million which beat the analyst consensus estimate of $46.196 million by 0.46 percent. This is a 9.58 percent increase over sales of $42.350 million the same period last year.

PDFS

PDF Solutions Q3 2024 Adj. EPS $0.25 Beats $0.20 Estimate, Sales $46.409M Beat $46.196M Estimate

TELA Bio (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TELA#NASDAQ">TELA</a>) affirms FY2024 sales outlook from $74.50 million-76.50 million to $74.50 million-76.50 million.

TELA

TELA Bio Affirms FY2024 Sales Guidance from $74.50M-76.50M to $74.50M-76.50M

Iovance Biotherapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IOVA#NASDAQ">IOVA</a>) affirms FY2025 Product sales outlook from $450.00 million-475.00 million to $450.00 million-475.00 million.

IOVA

Iovance Biotherapeutics Affirms FY2025 Product Sales Guidance from $450.00M-475.00M to $450.00M-475.00M

Collegium Pharmaceutical (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/COLL#NASDAQ">COLL</a>) raises FY2024 sales outlook from $580.00 million-595.00 million to $620.00 million-635.00 million.

COLL

Collegium Pharmaceutical Raises FY2024 Sales Guidance from $580.00M-595.00M to $620.00M-635.00M  VS Est.625.37M

CPAY

Corpay Expects Q4 Total Revenues Of $1.04B - $1.07B, Adjusted EP Of $5.25 - $5.45

Iovance Biotherapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IOVA#NASDAQ">IOVA</a>) affirms FY2024 Product sales outlook from $160.00 million-165.00 million to $160.00 million-165.00 million.

Iovance Biotherapeutics Affirms FY2024 Product Sales Guidance from $160.00M-165.00M to $160.00M-165.00M

Telus acquires additional shares of Telus digital

Morgan Stanley analyst James Faucette maintained a Hold rating on TELUS International (CDA) (TIXT – Research Report) today and set a price target o...

TELUS International (CDA) (TIXT) Receives a Hold from Morgan Stanley

TELUS International: TIXT To Speech-Less

TELUS: The Government Gets This One Right

Analysts have been eager to weigh in on the Technology sector with new ratings on BlackBerry (BB – Research Report), Intuit (INTU – Research Report...

Analysts Have Conflicting Sentiments on These Technology Companies: BlackBerry (BB), Intuit (INTU) and TELUS International (CDA) (TIXT)

TELUS buys more shares of TELUS Digital

TELUS International (CDA) (TSE:TIXT) has released an update. TELUS Corporation has strategically increased its stake in TELUS Digital by acquiring ...

TELUS Bolsters Stake in TELUS Digital

Top Canadian telecoms asked to lower international, domestic roaming fees by regulator

ClearBridge Canadian Equity Strategy Q3 2024 Commentary

Analysts have been eager to weigh in on the Technology sector with new ratings on TELUS International (CDA) (TIXT – Research Report), Gen Digital (...

Analysts Have Conflicting Sentiments on These Technology Companies: TELUS International (CDA) (TIXT), Gen Digital (GEN) and Pegasystems (PEGA)

AETUF

ANCTF

BYDGF

CDDRF

CFCV

CIGI

DLMAF

ENBNF

ENBOF

ENBRF

ENNPF

FORFF

FRTSF

FTPSF

FTRSF

IAFNF

INFR

INTU

LBLCF

LBLPF

LRGE

MNLCF

MNQFF

MNUFF

PARXF

PEGA

RCIAF

SAPIF

SHOP

SLFIF

SNCAF

SNLIF

SUNFF

SVNDF

SVNDY

TDBCP

TIXT

TNTTF

YLDE

Entertainment

Press Releases

General

MEDIA INVITATION - Sommet Émergence: Innovation et Technologie by Zú, presented by TELUS in collaboration with Vibrant Studios

Growing concerns in Canada and United States about data privacy and ethical data practices: TELUS poll

Growing concerns about data privacy and ethical data practices: TELUS poll

TELUS Digital will release third quarter 2024 results and host an investor call on November 8

Contracts

TELUS originals celebrates 10 years of powerful storytelling

TELUS Digital Earns Leader Ranking from NelsonHall in CX Services for High Tech and Automotive Sectors

TELUS collaborates with Google Cloud and Onix to modernize data storage and supercharge AI-powered innovation

TELUS and Photonic join forces to build Canada's quantum future

TELUS announces 2024 #StandWithOwners winners, investing over $1 million into Canadian small businesses

Comments

TELUS Intl

Notizie

Ultime notizie per TELUS Intl (NYSE:TIXT) Azioni

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO